Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VSTM

Verastem (VSTM)

Verastem Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VSTM
DateTimeSourceHeadlineSymbolCompany
12/20/20224:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
12/20/20224:08PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:VSTMVerastem Inc
12/20/20224:08PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:VSTMVerastem Inc
12/20/20224:07PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:VSTMVerastem Inc
12/20/20224:07PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:VSTMVerastem Inc
12/20/20224:06PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:VSTMVerastem Inc
12/15/20225:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
12/15/20225:23PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VSTMVerastem Inc
12/15/20224:30PMBusiness WireVerastem Oncology Appoints Rob Gagnon to Board of DirectorsNASDAQ:VSTMVerastem Inc
11/09/20228:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
11/07/20227:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
11/07/20226:15AMTipRanksVerastem (VSTM) Receives a Buy from H.C. WainwrightNASDAQ:VSTMVerastem Inc
11/03/20224:37PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VSTMVerastem Inc
11/03/20224:05PMBusiness WireVerastem Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company ProgressNASDAQ:VSTMVerastem Inc
10/24/20224:06PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VSTMVerastem Inc
10/20/20228:26AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
10/20/20227:00AMBusiness WireVerastem Oncology Appoints Anil Kapur to Board of DirectorsNASDAQ:VSTMVerastem Inc
10/07/20224:05PMBusiness WireVerastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VSTMVerastem Inc
10/04/20227:00AMBusiness WireVerastem Oncology Announces RAMP VS-6766 Clinical Trials and Corporate UpdatesNASDAQ:VSTMVerastem Inc
09/30/20229:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
09/28/20226:15AMTipRanksH.C. Wainwright Sticks to Its Buy Rating for Verastem (VSTM)NASDAQ:VSTMVerastem Inc
09/21/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
09/21/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
09/21/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
08/09/20226:20AMTipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:VSTMVerastem Inc
08/08/20227:42AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSTMVerastem Inc
08/08/20227:00AMBusiness WireVerastem Oncology Reports Second Quarter 2022 Financial Results and Highlights Recent Company ProgressNASDAQ:VSTMVerastem Inc
08/02/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
07/07/20227:00AMBusiness WireVerastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VSTMVerastem Inc
06/24/20224:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSTMVerastem Inc
 Showing the most relevant articles for your search:NASDAQ:VSTM